Notably, the JAK/STAT signaling pathway has been reported to be very important in hematological diseases [16] and many solid tumors, such as cervical cancer [17], breast cancer [18], hepatocellular carcinoma [19, 20], and acute myeloid leukemia (AML) [21]. This evidence concerns the gene SOAT1 and acute myeloid leukemia.